| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.4M | +46.7% |
| SG&A Expense | $21.4M | +112.7% |
| Operating Income | -$68.9M | -62.4% |
| Income Tax | $0 | — |
| Net Income | -$68.3M | -57.8% |
| EPS (Basic) | -$2.16 | +92.4% |
| EPS (Diluted) | -$2.16 | +92.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.6M | +104.1% |
| Current Assets | $197.8M | +102.9% |
| Total Assets | $200.4M | +95.6% |
| Current Liabilities | $11.3M | +14.5% |
| Total Liabilities | $11.3M | +13.7% |
| Stockholders' Equity | $189.1M | +372.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$65.1M | -65.6% |
| Capital Expenditures | $921K | +351.5% |
| Investing Cash Flow | -$921K | -351.5% |
| Financing Cash Flow | $161.3M | +49.7% |
| Free Cash Flow | -$66.1M | -67.1% |